REALITY MONITORING AND DOPAMINE
ConditionNeurosciences
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-45
SponsorHôpital le Vinatier
About this trial
Reality-monitoring characterizes the ability to determine whether information was perceived in the environment or only imagined . Impaired reality-monitoring abilities have been associated with hallucinations in patients with schizophrenia and patients with Parkinson's disease.
The investigators hypothesize a link between dopaminergic (DA) transmission and reality-monitoring.
Eligibility criteria
Qualifiers
Healthy volunteers who have given their written informed consent
Men and women from 18 to 45 years old
Normal or corrected vision
Being fluent in French or French for native language
Disqualifiers
Healthy volunteers who have given their written informed consent
Men and women from 18 to 45 years old
Normal or corrected vision
Being fluent in French or French for native language
Trial design
Treatments tested in this trial
- Précurseur de la dopamine
- antagoniste D2
- PLACEBO
Treatment groups
39 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov